Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 484 News Items found Decoder What Is Apoptosis? Friday, May 16, 2014 Cell biologist Michael Overholtzer explains apoptosis, a form of programmed cell death that can lead to cancer when it doesn’t function properly. Super Vision: How New Imaging Technologies Are Transforming Biomedical Research Wednesday, May 26, 2021 With the power of advanced microscopes, Sloan Kettering Institutes scientists are pushing the boundaries of what can be seen and measured. In the Lab More Evidence that Cellular ‘Death by Iron’ Could Be Promising Avenue of Cancer Treatment Monday, November 23, 2020 Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death. Feature How a Chicken Helped Solve the Mystery of Cancer Wednesday, December 27, 2017 When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science. In the Clinic The Truth Behind Four Natural Cancer “Cures” Tuesday, June 25, 2024 The internet is full of “miracle cures” for cancer and alleged surefire ways to prevent it, and well-meaning people may urge cancer patients to just tr... Education MSK’s Summer Cancer Research Program Gives Opportunity to Diverse College Students Thursday, August 29, 2024 A summer program offers college students from underrepresented communities a chance to get valuable research experience. Feature First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type Monday, November 26, 2018 Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time. At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions Wednesday, April 13, 2022 Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses. In the Lab Resistance Is Futile: Targeted Treatment Makes Stubborn Cancers Responsive to Immunotherapy Wednesday, November 9, 2016 New research on an experimental drug provides hope for better responses to immunotherapy. Finding Definitive Study Shows That People with Melanoma Do Not Need Immediate Lymph Node Removal Thursday, June 8, 2017 The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma. Pagination First page « First Previous page ‹ Previous … Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Page 42 Page 43 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment